PFM.08 Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction in pregnant women

Abstract

The EVERREST programme proposes a clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction (FGR) in pregnant women. FGR is...